Literature DB >> 12804600

Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart.

Roland Kiewitz1, Christian Acklin, Beat W Schäfer, Bohumil Maco, Branislav Uhrík, Frank Wuytack, Paul Erne, Claus W Heizmann.   

Abstract

The Ca(2+)-binding S100A1 protein displays a specific and high expression level in the human myocardium and is considered to be an important regulator of heart contractility. Diminished protein levels detected in dilated cardiomyopathy possibly contribute to impaired Ca(2+) handling and contractility in heart failure. To elucidate the S100A1 signaling pathway in the human heart, we searched for S100A1 target proteins by applying S100A1-specific affinity chromatography and immunoprecipitation techniques. We detected the formation of a Ca(2+)-dependent complex of S100A1 with SERCA2a and PLB in the human myocardium. Using confocal laser scanning microscopy, we showed that all three proteins co-localize at the level of the SR in primary mouse cardiomyocytes and confirmed these results by immunoelectron microscopy in human biopsies. Our results support a regulatory role of S100A1 in the contraction-relaxation cycle in the human heart.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12804600     DOI: 10.1016/s0006-291x(03)00987-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

2.  S100A1 promotes action potential-initiated calcium release flux and force production in skeletal muscle.

Authors:  Benjamin L Prosser; Erick O Hernández-Ochoa; Richard M Lovering; Zoita Andronache; Danna B Zimmer; Werner Melzer; Martin F Schneider
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-04       Impact factor: 4.249

3.  Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.

Authors:  Patrick Most; Sven T Pleger; Mirko Völkers; Beatrix Heidt; Melanie Boerries; Dieter Weichenhan; Eva Löffler; Paul M L Janssen; Andrea D Eckhart; Jeffrey Martini; Matthew L Williams; Hugo A Katus; Andrew Remppis; Walter J Koch
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Genetic polymorphism and protein conformational plasticity in the calmodulin superfamily: two ways to promote multifunctionality.

Authors:  Mitsuhiko Ikura; James B Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

5.  S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling.

Authors:  Benjamin L Prosser; Nathan T Wright; Erick O Hernãndez-Ochoa; Kristen M Varney; Yewei Liu; Rotimi O Olojo; Danna B Zimmer; David J Weber; Martin F Schneider
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

Review 6.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

Review 7.  Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?

Authors:  Amanda L Denniss; Alexander M Dashwood; Peter Molenaar; Nicole A Beard
Journal:  Biophys Rev       Date:  2020-07-22

8.  Molecular Basis of S100A1 Activation at Saturating and Subsaturating Calcium Concentrations.

Authors:  Caitlin E Scott; Peter M Kekenes-Huskey
Journal:  Biophys J       Date:  2016-03-08       Impact factor: 4.033

Review 9.  S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function.

Authors:  Mirko Völkers; David Rohde; Chelain Goodman; Patrick Most
Journal:  J Biomed Biotechnol       Date:  2010-03-28

Review 10.  S100A1: a multifaceted therapeutic target in cardiovascular disease.

Authors:  David Rohde; Julia Ritterhoff; Mirko Voelkers; Hugo A Katus; Thomas G Parker; Patrick Most
Journal:  J Cardiovasc Transl Res       Date:  2010-07-20       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.